SCHEMBL19626575

SCHEMBL19626575

Cc1nc(-c2c(Cl)cc(Cl)cc2Cl)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.49
MAPT P10636 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
GAA P10253 4/20 0.43
RECQL P46063 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
ESR2 Q92731 1/20 0.43
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 1/20 0.39
GRM5 P41594 1/20 0.38
KDM4A O75164 1/20 0.38
KDM4B O94953 1/20 0.38
KDM5C P41229 1/20 0.38
KDM5B Q9UGL1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626559 0.82 RECQL (0.49) RAB9ANPC1MAPTGAARECQL
SCHEMBL19625348 0.79 COMT (0.34) RAB9ANPC1MAPTL3MBTL1ALDH1A1
SCHEMBL8698255 0.78 MAPT (0.53) RAB9ANPC1MAPTL3MBTL1GAA
SCHEMBL1914914 0.78 LTA4H (0.47) RAB9ANPC1MAPTALDH1A1KDM4E
SCHEMBL24359598 0.75 GAA (0.52) RAB9ANPC1MAPTGAARECQL
SCHEMBL19626573 0.74 GAA (0.50) RAB9ANPC1MAPTGAARECQL
SCHEMBL19627007 0.74 RAB9A (0.44) RAB9ANPC1MAPTL3MBTL1GAA
SCHEMBL19626737 0.73 RECQL (0.44) RAB9ANPC1MAPTGAARECQL
SCHEMBL1765097 0.73 TSHR (0.44) RAB9ANPC1MAPTGAARECQL
SCHEMBL21143970 0.72 RAB9A (0.45) RAB9ANPC1MAPTGAARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 RAB9A 3162/4885NPC1 2489/4885MAPT 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.